MAP2K5 and breast cancer: The MEK5-ERK5 signaling cascade was identified as an essential effector of TGFβ-mediated EMT, using a high-content microscopy screen and a kinome-wide siRNA library, in normal mammary epithelial cells and breast cancer cells [64].